{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:37:44Z","timestamp":1793079464642,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10741-022-10261-7","type":"journal-article","created":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T22:02:20Z","timestamp":1658095340000},"page":"2059-2065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Cardiovascular disease associated with methamphetamine use: a review"],"prefix":"10.1007","volume":"27","author":[{"given":"Jared","family":"Tobolski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2881-3754","authenticated-orcid":false,"given":"Maxwell Eyram","family":"Afari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"issue":"2","key":"10261_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ehf2.12572","volume":"7","author":"V Schwarzbach","year":"2020","unstructured":"Schwarzbach V, Lenk K, Laufs U (2020) Methamphetamine-related cardiovascular diseases. ESC Heart Fail 7(2):407\u2013414","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10261_CR2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jchf.2018.01.004","volume":"6","author":"O Ben-Yehuda","year":"2018","unstructured":"Ben-Yehuda O, Siecke N (2018) Crystal methamphetamine: a drug and cardiovascular epidemic. JACC Heart Fail 6(3):219\u2013221","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10261_CR3","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","volume":"39","author":"CG Kevil","year":"2019","unstructured":"Kevil CG et al (2019) Methamphetamine use and cardiovascular disease. Arterioscler Thromb Vasc Biol 39(9):1739\u20131746","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10261_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jchf.2017.10.006","volume":"6","author":"SX Zhao","year":"2018","unstructured":"Zhao SX et al (2018) Clinical characteristics and outcome of methamphetamine-associated pulmonary arterial hypertension and dilated cardiomyopathy. JACC Heart Fail 6(3):209\u2013218","journal-title":"JACC Heart Fail"},{"key":"10261_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108029","volume":"212","author":"JL Freeling","year":"2020","unstructured":"Freeling JL, McFadden LM (2020) The emergence of cardiac changes following the self-administration of methamphetamine. Drug Alcohol Depend 212:108029","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10261_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.hlc.2016.11.005","volume":"26","author":"ED Paratz","year":"2017","unstructured":"Paratz ED et al (2017) Is an abnormal ECG just the tip of the ice-berg? examining the utility of electrocardiography in detecting methamphetamine-induced cardiac pathology. Heart Lung Circ 26(7):684\u2013689","journal-title":"Heart Lung Circ"},{"issue":"1","key":"10261_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12012-016-9385-8","volume":"17","author":"M JafariGiv","year":"2017","unstructured":"JafariGiv M (2017) Exposure to amphetamines leads to development of amphetamine type stimulants associated cardiomyopathy (ATSAC). Cardiovasc Toxicol 17(1):13\u201324","journal-title":"Cardiovasc Toxicol"},{"issue":"12","key":"10261_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","volume":"69","author":"CM Jones","year":"2020","unstructured":"Jones CM, Compton WM, Mustaquim D (2020) Patterns and characteristics of methamphetamine use among adults - United States, 2015\u20132018. MMWR Morb Mortal Wkly Rep 69(12):317\u2013323","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10261_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.120.007638","volume":"14","author":"SX Zhao","year":"2021","unstructured":"Zhao SX et al (2021) Socioeconomic burden of rising methamphetamine-associated heart failure hospitalizations in California from 2008 to 2018. Circ Cardiovasc Qual Outcomes 14(7):e007638","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10261_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.amjcard.2019.05.068","volume":"124","author":"M Nishimura","year":"2019","unstructured":"Nishimura M et al (2019) Characteristics and outcomes of methamphetamine abuse among veterans with heart failure. Am J Cardiol 124(6):907\u2013911","journal-title":"Am J Cardiol"},{"issue":"9","key":"10261_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamapsychiatry.2020.0246","volume":"77","author":"MP Paulus","year":"2020","unstructured":"Paulus MP, Stewart JL (2020) Neurobiology, clinical presentation, and treatment of methamphetamine use disorder: a review. JAMA Psychiat 77(9):959\u2013966","journal-title":"JAMA Psychiat"},{"issue":"7","key":"10261_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1081\/CLT-120026521","volume":"41","author":"M Wijetunga","year":"2003","unstructured":"Wijetunga M et al (2003) Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol 41(7):981\u2013986","journal-title":"J Toxicol Clin Toxicol"},{"issue":"9","key":"10261_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jama.1991.03460090100040","volume":"265","author":"R Hong","year":"1991","unstructured":"Hong R, Matsuyama E, Nur K (1991) Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 265(9):1152\u20131154","journal-title":"JAMA"},{"issue":"3","key":"10261_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000106681","volume":"109","author":"S Srikanth","year":"2008","unstructured":"Srikanth S, Barua R, Ambrose J (2008) Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. Cardiology 109(3):188\u2013192","journal-title":"Cardiology"},{"issue":"4","key":"10261_CR15","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1016\/S0167-5273(08)70628-4","volume":"19","author":"JP Chen","year":"2007","unstructured":"Chen JP (2007) Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm. J Invasive Cardiol 19(4):E89-92","journal-title":"J Invasive Cardiol"},{"issue":"Suppl 1","key":"10261_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1360-0443.2006.01776.x","volume":"102","author":"W Haning","year":"2007","unstructured":"Haning W, Goebert D (2007) Electrocardiographic abnormalities in methamphetamine abusers. Addiction 102(Suppl 1):70\u201375","journal-title":"Addiction"},{"issue":"3","key":"10261_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.drugalcdep.2012.11.016","volume":"129","author":"WJ Panenka","year":"2013","unstructured":"Panenka WJ et al (2013) Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 129(3):167\u2013179","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10261_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12974-018-1385-0","volume":"15","author":"F Shaerzadeh","year":"2018","unstructured":"Shaerzadeh F et al (2018) Methamphetamine neurotoxicity, microglia, and neuroinflammation. J Neuroinflammation 15(1):341","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10261_CR19","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/s41467-017-02087-x","volume":"8","author":"DO Sambo","year":"2017","unstructured":"Sambo DO et al (2017) The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission. Nat Commun 8(1):2228","journal-title":"Nat Commun"},{"issue":"11","key":"10261_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016704","volume":"9","author":"PKV Reddy","year":"2020","unstructured":"Reddy PKV et al (2020) Clinical characteristics and management of methamphetamine-associated cardiomyopathy: state-of-the-art review. J Am Heart Assoc 9(11):e016704","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10261_CR21","first-page":"581","volume":"63","author":"JP Jiang","year":"1990","unstructured":"Jiang JP, Downing SE (1990) Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms. Yale J Biol Med 63(6):581\u2013591","journal-title":"Yale J Biol Med"},{"issue":"1","key":"10261_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0163-7258(03)00052-4","volume":"99","author":"JM Brown","year":"2003","unstructured":"Brown JM, Yamamoto BK (2003) Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 99(1):45\u201353","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10261_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/clc.22195","volume":"36","author":"S Won","year":"2013","unstructured":"Won S et al (2013) Methamphetamine-associated cardiomyopathy. Clin Cardiol 36(12):737\u2013742","journal-title":"Clin Cardiol"},{"issue":"8","key":"10261_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1360-0443.2008.02231.x","volume":"103","author":"S Kaye","year":"2008","unstructured":"Kaye S et al (2008) Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addiction 103(8):1353\u20131360","journal-title":"Addiction"},{"key":"10261_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.drugalcdep.2017.07.001","volume":"179","author":"S Darke","year":"2017","unstructured":"Darke S, Duflou J, Kaye S (2017) Prevalence and nature of cardiovascular disease in methamphetamine-related death: a national study. Drug Alcohol Depend 179:174\u2013179","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10261_CR26","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.4049\/jimmunol.0903691","volume":"185","author":"R Potula","year":"2010","unstructured":"Potula R et al (2010) Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J Immunol 185(5):2867\u20132876","journal-title":"J Immunol"},{"key":"10261_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.725839","volume":"12","author":"TJ Phillips","year":"2021","unstructured":"Phillips TJ et al (2021) Confirmation of a causal Taar1 allelic variant in addiction-relevant methamphetamine behaviors. Front Psychiatry 12:725839","journal-title":"Front Psychiatry"},{"issue":"2","key":"10261_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/jnr.23697","volume":"94","author":"JW Seo","year":"2016","unstructured":"Seo JW et al (2016) Methamphetamine induces the release of endothelin. J Neurosci Res 94(2):170\u2013178","journal-title":"J Neurosci Res"},{"issue":"4","key":"10261_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00210-010-0554-1","volume":"382","author":"M Fehler","year":"2010","unstructured":"Fehler M et al (2010) Identification of trace-amine-associated receptors (TAAR) in the rat aorta and their role in vasoconstriction by beta-phenylethylamine. Naunyn Schmiedebergs Arch Pharmacol 382(4):385\u2013398","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10261_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/bjp.2008.286","volume":"155","author":"AA Herbert","year":"2008","unstructured":"Herbert AA, Kidd EJ, Broadley KJ (2008) Dietary trace amine-dependent vasoconstriction in porcine coronary artery. Br J Pharmacol 155(4):525\u2013534","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10261_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuropharm.2005.04.016","volume":"49","author":"EC Nguyen","year":"2005","unstructured":"Nguyen EC et al (2005) Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 49(5):638\u2013645","journal-title":"Neuropharmacology"},{"issue":"1","key":"10261_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s42003-020-01408-z","volume":"3","author":"CS Abdullah","year":"2020","unstructured":"Abdullah CS et al (2020) Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function. Commun Biol 3(1):682","journal-title":"Commun Biol"},{"issue":"2","key":"10261_CR33","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/genes12020139","volume":"12","author":"I Pontisso","year":"2021","unstructured":"Pontisso I, Combettes L (2021) Role of Sigma-1 receptor in calcium modulation: possible involvement in cancer. Genes 12(2):139","journal-title":"Genes"},{"issue":"27","key":"10261_CR34","doi-asserted-by":"publisher","first-page":"11250","DOI":"10.1074\/jbc.M116.774075","volume":"292","author":"WC Hong","year":"2017","unstructured":"Hong WC et al (2017) The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats. J Biol Chem 292(27):11250\u201311261","journal-title":"J Biol Chem"},{"issue":"20","key":"10261_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009775","volume":"7","author":"CS Abdullah","year":"2018","unstructured":"Abdullah CS et al (2018) Cardiac dysfunction in the Sigma 1 receptor knockout mouse associated with impaired mitochondrial dynamics and bioenergetics. J Am Heart Assoc 7(20):e009775","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10261_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1254\/jphs.12R13CP","volume":"121","author":"MS Bhuiyan","year":"2013","unstructured":"Bhuiyan MS, Tagashira H, Fukunaga K (2013) Crucial interactions between selective serotonin uptake inhibitors and sigma-1 receptor in heart failure. J Pharmacol Sci 121(3):177\u2013184","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"10261_CR37","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1038\/sj.npp.1301578","volume":"33","author":"CL Hart","year":"2008","unstructured":"Hart CL et al (2008) Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology 33(8):1847\u20131855","journal-title":"Neuropsychopharmacology"},{"key":"10261_CR38","doi-asserted-by":"crossref","unstructured":"Osekowski M et al (2022)\u00a0A comprehensive approach to managing methamphetamine-associated cardiomyopathy. Am\u00a0J Cardiovasc Drugs","DOI":"10.1007\/s40256-022-00523-y"},{"issue":"17","key":"10261_CR39","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"A Heidenreich Paul","year":"2022","unstructured":"Heidenreich Paul A et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure. J Am Coll Cardiol 79(17):e263\u2013e421","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10261_CR40","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.intimp.2006.01.008","volume":"6","author":"WB Gentry","year":"2006","unstructured":"Gentry WB et al (2006) Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats. Int Immunopharmacol 6(6):968\u2013977","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10261_CR41","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/JCP.0b013e318221b2db","volume":"31","author":"RJ Sevak","year":"2011","unstructured":"Sevak RJ et al (2011) Discriminative-stimulus, subject-rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole. J Clin Psychopharmacol 31(4):470\u2013480","journal-title":"J Clin Psychopharmacol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-022-10261-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-022-10261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T03:19:06Z","timestamp":1665112746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-022-10261-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10261"],"URL":"https:\/\/doi.org\/10.1007\/s10741-022-10261-7","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"assertion":[{"value":"10 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}